Cargando…

Combination of NK cells therapy and oral administration of entinostat as an approach for osteosarcoma lung metastasis treatment

Detalles Bibliográficos
Autores principales:	Kiany, Simin, Yu, Ling, Kleinerman, Eugenie S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646098/ http://dx.doi.org/10.1186/2051-1426-3-S2-P25

Ejemplares similares

Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma
por: Yang, Yuanzheng, et al.
Publicado: (2015)

Immune modulation through targeting PD-1/PDL-1 signaling pathway for the treatment of osteosarcoma lung metastastasis
por: Dhupkar, Pooja M, et al.
Publicado: (2015)

Evaluation of aerosol IL-2 in sarcoma patients with lung metastases for future combination therapy with infused natural killer cells
por: Naing, Aung, et al.
Publicado: (2013)

Targeting SALL4 by entinostat in lung cancer
por: Yong, Kol Jia, et al.
Publicado: (2016)

Osteosarcoma Overview
por: Lindsey, Brock A., et al.
Publicado: (2016)

Epigenetic Regulation of Apoptosis and Cell Cycle in Osteosarcoma
por: Rao-Bindal, Krithi, et al.
Publicado: (2011)

Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming
por: Yang, Yuanzheng, et al.
Publicado: (2022)

Revisiting entinostat as an immune-potentiating adjuvant
por: McCaw, Tyler R., et al.
Publicado: (2018)

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2019)

Entinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway
por: Idso, John M., et al.
Publicado: (2020)

Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing
por: Kleinerman, Eugenie S., et al.
Publicado: (2018)

Radiation-induction of MMPs limited the NK-mediated anticancer immunity in lung cancer cells
por: Heo, Woong, et al.
Publicado: (2014)

Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases
por: Graat, Harm CA, et al.
Publicado: (2008)

P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
por: Sconocchia, G, et al.
Publicado: (2014)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023)

Interferon Gamma Induces Changes in Natural Killer (NK) Cell Ligand Expression and Alters NK Cell-Mediated Lysis of Pediatric Cancer Cell Lines
por: Aquino-López, Arianexys, et al.
Publicado: (2017)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions
por: Wolf-Dennen, Kerri, et al.
Publicado: (2020)

P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses
por: Pellegatta, S, et al.
Publicado: (2014)

Combination radioimmunotherapy with adoptive NK transfer targets cancer stem cells in canine models of bone and soft tissue sarcoma
por: Canter, Robert, et al.
Publicado: (2015)

P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT + PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO HYPOMETHYLATING AGENTS
por: Bewersdorf, Jan, et al.
Publicado: (2023)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells
por: Morishima, Chihiro, et al.
Publicado: (2014)

TLR-independent activation of NK cells during systemic inflammation
por: Rasid, O, et al.
Publicado: (2014)

The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways
por: Glaichenhaus, Nicolas, et al.
Publicado: (2011)

P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)
por: Specht, HM, et al.
Publicado: (2014)

Pharmacovigilance for single low-dose primaquine: a practical approach
por: Poirot, Eugenie, et al.
Publicado: (2014)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
por: Thobakgale, CF, et al.
Publicado: (2012)

Expression and function of FcγRII on NK cells in rhesus macaques
por: He, X, et al.
Publicado: (2012)

P24. Aviscumine enhances NK- cytotoxicity against tumor cells
por: Gamerith, G, et al.
Publicado: (2014)

Genomic scale analysis of NK cells impact on response to IFN-α
por: Ascierto, Maria L, et al.
Publicado: (2013)

Periodic fevers associated with celiac disease and marked increase of NK cells
por: Sediva, A
Publicado: (2015)

Oral metastasis of chondroblastic osteosarcoma
por: Dumpala, Rakesh Kumar, et al.
Publicado: (2012)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
por: Morishima, Chihiro, et al.
Publicado: (2015)

Oral ATP administration improves blood flow response to exercise in an animal model and in resistance trained athletes
por: Lowery, Ryan P, et al.
Publicado: (2013)

Human mast cells respond to viral infection by recruiting NK cells and T cells
por: Burke, SM, et al.
Publicado: (2010)

Cbl-b silenced human NK cells respond stronger to cytokine stimulation
por: Lametschwandtner, Guenther, et al.
Publicado: (2015)

NK cells protect TCR-transgenic mice from developing fetal leukemia
por: Dubois, Sigrid, et al.
Publicado: (2014)

Improving early administration of antibiotics: a 'Plan Do Study Act' approach
por: Revill, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d0jstc6bjuq6b1on0apk79gjtl